Additionally, we profiled tumor samples from ER+ patients, patients with TNBC and patients with MBC to demonstrate Starfysh’s utility for spatial mapping of intertumoral and intratumoral heterogeneity and studying the role of microenvironmental niches in determining localized immune response. The gene discussed is ESR1; the disease is neoplasm.